Coronavirus tests performed in labs are the gold standard for accuracy and antigen tests are a fast and inexpensive alternative.
But backers of a third type of test, developed by a Nobel Prize winner using cutting-edge CRISPR technology, say it has the potential to be all three: rapid, accurate and inexpensive.
Although these gene-editing technology tests are still being developed and won’t be ready in the United States this year as the weather cools and demand surges, research groups recently published scientific papers describing them as an appealing alternative as testing shortages persist in the COVID-19 pandemic.
Dr. Jennifer Doudna, a University of California, Berkeley researcher whose pioneering work in CRISPR earned a share of this year’s Nobel Prize in chemistry, said the test can be done quickly and doesn’t require a lab.
“We have a ways to go before CRISPR-based diagnostics reach widespread use, but I believe we’ll see an impact during the current pandemic,” Doudna said. “Because it is simple to adjust these tests to detect other targets, the platform we’re developing now is laying the groundwork to deploy CRISPR for rapid diagnosis during future outbreaks.”
CRISPR, or clustered regularly interspaced short palindromic repeats, is a gene-editing technology studied for a wide range of uses from cancer and sickle cell disease treatments to improved food production.
In 2016, Doudna’s lab developed a way to detect RNA using the technology. Her lab collaborated with Dr. Melanie Ott of San Francisco-based Gladstone Institutes to develop an HIV test, but when the pandemic hit, the researchers focused on developing a coronavirus test.
The test recognizes a sequence of RNA in SARS-CoV-2, the coronavirus that causes COVID-19
In an Oct. 12 publication, researchers reported the test yielded results in five minutes and correctly identified five samples from patients with coronavirus. When used with a mobile phone to detect signals generated by the test, the technology could provide a fast, low-cost test outside a laboratory, researchers said in the paper, which was not peer reviewed.
Massachusetts Institute of Technology scientists also are honing a CRISPR-based test that can be used outside a lab. In a New England Journal of Medicine letter published last month, researchers said the test was evaluated at a University of Washington lab using 202 samples with coronavirus and 200 without. The test correctly identified 93.1% of positive samples. The test also had 98.5% specificity, which means it rarely reported false positives.
Feluda, a paper-based CRISPR test named after a fictional India detective, has been cleared by that nation’s drug regulators for commercial launch. But it’s unclear how the Indian conglomerate Tata Group plans to deploy the test in India, which trails only the United States with nearly 7.7 million cases, according to data from Johns Hopkins University.
Image Credit: Ernesto Del Aguila, NHGRI
Post by Amanda Scott, NA CEO. Follow her on twitter @tantriclens
Thanks to Heinz V. Hoenen. Follow him on twitter: @HeinzVHoenen

News
New material discovery could revolutionize roll-out of global vaccinations
New raw vaccine materials that could make vaccines more accessible, sustainable, and ethical have been discovered. The results of the research have been published in Polymers. Adjuvants are vaccine ingredients that boost a person's immune response [...]
Scientists Develop Incredibly Lightweight Material 4 Times Stronger Than Steel
Researchers developed a light yet strong material by combining two unexpected ingredients—DNA and glass. Working at the nanoscale provides scientists with a deep understanding and precision in crafting and analyzing materials. In broader-scale production, and even [...]
New Implant Doctors Hope Will Cut Cancer Deaths in Half
Researchers at Houston's Rice University are developing an implant that could diminish deaths caused by cancer by half. The device will contain synthetically nurtured human cells and be embedded with sensors to keep track of cancer [...]
Machine learning helps predict drugs’ favorite subcellular haunts
Most drugs are small molecules that bind firmly to a specific target—some molecule in human cells that is involved in a disease—in order to work. For example, a cancer drug's target might be a [...]
Nanotechnology Breakthrough Could Help Treat Blindness
Scientists utilize nanotechnology to address a prevalent cause of vision loss. Scientists have discovered a way to use nanotechnology to create a 3D ‘scaffold’ to grow cells from the retina. This breakthrough could lead [...]
Decoding Women’s Health: Artificial Intelligence Revolutionizes PCOS Diagnosis
NIH study reviews 25 years of data and finds AI/ML can detect common hormone disorder. Artificial intelligence (AI) and machine learning (ML) can effectively detect and diagnose Polycystic Ovary Syndrome (PCOS), which is the most common [...]
Surprising Discovery Could Explain How Coronaviruses Jump Species
New insights are enhancing scientists’ efforts to stay ahead of COVID-19 and the next pandemic. Unexpected new insights into the ways COVID-19 infects cells could shed light on the virus’s adept ability to jump from one species to another [...]
A blood test for long Covid is possible, a study suggests
Scientists can now show key differences in the blood of those who recover from Covid — and those who don't. More than three years into the pandemic, the millions of people who have suffered [...]
FedEx for your cells: this biological delivery service could treat disease
Researchers want to know why cells produce tiny packages called vesicles — and whether these bundles could be used for therapy. Graça Raposo was a young postdoc in the Netherlands in 1996 when she [...]
New study on the genetic magnetization of living bacteria shows great potential for biomedicine
Magnetic bacteria possess extraordinary capabilities due to the magnetic nanoparticles, the magnetosomes, which are concatenated inside their cells. A research team at the University of Bayreuth has now transferred all of the approximately 30 [...]
Ultrathin Nanotech Promises to Help Tackle Antibiotic Resistance
Researchers have invented a nano-thin superbug-slaying material that could one day be integrated into wound dressings and implants to prevent or heal bacterial infections. The innovation – which has undergone advanced pre-clinical trials – [...]
Researchers Discover New Mnemomic Networks in the Brain
The medial temporal lobe (MTL) houses the human memory system. Broadly, it contains the hippocampus, parahippocampal cortex, perirhinal cortex, and entorhinal cortex. “One big challenge in studying the MTL is its great anatomical variability [...]
The Surprising Origin of a Deadly Hospital Infection
C. diff might not originate from external transmission but rather from within the infected patient themselves. Hospital staff dedicate significant effort to safeguard patients from infections during their hospital stay. Through practices ranging from [...]
Google AI breakthrough – huge step in finding genes that cause diseases
Google says it has made a significant step in identifying disease-causing genes, which could help spot rare genetic disorders. A new model named AlphaMissense is able to confidently classify 89 per cent of all [...]
New Study: Everyday Pleasures Can Boost Cognitive Performance
MINDWATCH study reveals cognitive peaks with everyday pleasures. Listening to music and drinking coffee are the sorts of everyday pleasures that can impact a person’s brain activity in ways that improve cognitive performance, including [...]
Moderna reveals new highly targeted COVID-19 vaccine mRNA-1283
Moderna has developed a new and improved version of its COVID-19 vaccine. The unique formulation (mRNA-1283) reduces the vaccine's content from the full-length SARS-CoV-2 spike protein to a narrowly focused encoding of just two [...]